TY  - THES
U1  - Bachelor Thesis
A1  - Uth, Kristin
T1  - Investigating alternative therapeutic approaches for Erlotinib-resistant
and K-Rras mutant non-small cell lung cancer
N2  - Different small molecule kinase inhibitors, which have an influence on cell growth, proliferation and cell survival were tested alone and in combination with Erlotinib in the Erlotinib-resistant non-small cell lung cancer cell line PC-9ER and Cisplatin in the K-Ras mutant cell line H358. The aim was to find out, which  combinations produce the best antiproliferative effects in non-small cell lung cancer cell lines.
KW  - Inhibitor , Rezeptor-Tyrosinkinasen , Epidermaler Wachstumsfaktor-Rezeptor , Lungenkrebs , Zelllinie
Y2  - 2012
ER  -